AI assistant
Alkermes plc. — Director's Dealing 2011
Sep 20, 2011
31048_dirs_2011-09-20_5b1fe7b9-ee46-450d-8fc3-3d86670f87fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16
Reporting Person: BIBERSTEIN KATHRYN L (SVP, GC, Secretary, Alks, Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-16 | Common Stock | A | 32459 | — | Acquired | 32459 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $9.97 | A | 10500 | Acquired | 2013-04-25 | Common Stock (10500) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.57 | A | 25000 | Acquired | 2013-10-17 | Common Stock (25000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $12.16 | A | 39500 | Acquired | 2013-12-10 | Common Stock (39500) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $12.30 | A | 16875 | Acquired | 2014-07-12 | Common Stock (16875) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $12.30 | A | 5625 | Acquired | 2014-07-12 | Common Stock (5625) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $14.90 | A | 2067 | Acquired | 2014-12-17 | Common Stock (2067) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.90 | A | 50433 | Acquired | 2014-12-17 | Common Stock (50433) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $18.60 | A | 28374 | Acquired | 2015-12-09 | Common Stock (28374) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $18.60 | A | 5376 | Acquired | 2015-12-09 | Common Stock (5376) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $20.79 | A | 4218 | Acquired | 2016-05-02 | Common Stock (4218) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $20.79 | A | 12657 | Acquired | 2016-05-02 | Common Stock (12657) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.38 | A | 29145 | Acquired | 2016-12-12 | Common Stock (29145) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $14.38 | A | 855 | Acquired | 2016-12-12 | Common Stock (855) | Direct |
| 2011-09-16 | Incentive Stock Option (Right to Buy) | $15.95 | A | 5000 | Acquired | 2017-06-01 | Common Stock (5000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $15.95 | A | 15000 | Acquired | 2017-06-01 | Common Stock (15000) | Direct |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $14.13 | A | 15000 | Acquired | 2017-11-05 | Common Stock (15000) | Direct |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $12.29 | A | 45000 | Acquired | 2018-05-27 | Common Stock (45000) | Direct |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $8.55 | A | 65000 | Acquired | 2019-05-26 | Common Stock (65000) | Direct |
| 2011-09-16 | Restricted Stock Award | $0 | A | 4250 | Acquired | Common Stock (4250) | Direct | |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $9.21 | A | 30000 | Acquired | 2019-11-18 | Common Stock (30000) | Direct |
| 2011-09-16 | Restricted Stock Award | $0 | A | 11250 | Acquired | Common Stock (11250) | Direct | |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $11.74 | A | 86500 | Acquired | 2020-05-17 | Common Stock (86500) | Direct |
| 2011-09-16 | Restricted Stock Unit Award | $0 | A | 9375 | Acquired | Common Stock (9375) | Direct | |
| 2011-09-16 | Employee Stock Option (Right to Buy) | $18.105 | A | 100000 | Acquired | 2021-05-20 | Common Stock (100000) | Direct |
| 2011-09-16 | Restricted Stock Unit Award | $0 | A | 15000 | Acquired | Common Stock (15000) | Direct |
Footnotes
F1: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.
F2: These options are fully vested in accordance with their terms.
F3: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.
F4: 75% vested as of 9/16/11, remainder vests on 11/5/11.
F5: 75% vested as of 9/16/11, remainder vests on 5/27/12.
F6: 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.
F7: Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.
F8: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 11/18/11.
F9: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 5/17/12.
F10: Vests in 4 equal annual installments beginning on 5/20/12.